Howard Franklin
Chief Tech/Sci/R&D Officer presso ASSERTIO HOLDINGS, INC.
Profilo
Howard J.
Franklin is currently a Senior Vice President-Medical at Assertio Holdings, Inc. Prior to this, he worked as the Chief Medical Officer at Salix Pharmaceuticals Ltd.
from 2018 to 2022.
He also held the position of Chief Medical Officer at Finch Therapeutics Group, Inc. Dr. Franklin has an MBA from LaSalle University, an undergraduate degree from Lehigh University, and a doctorate from Drexel University College of Medicine.
Posizioni attive di Howard Franklin
Società | Posizione | Inizio |
---|---|---|
ASSERTIO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06/03/2023 |
Precedenti posizioni note di Howard Franklin
Società | Posizione | Fine |
---|---|---|
SALIX PHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
FINCH THERAPEUTICS GROUP, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Howard Franklin
LaSalle University | Masters Business Admin |
Lehigh University | Undergraduate Degree |
Drexel University College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
FINCH THERAPEUTICS GROUP, INC. | Health Services |
ASSERTIO HOLDINGS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
- Borsa valori
- Insiders
- Howard Franklin